Remimazolam with oliceridine for sedation in older adults during GI endoscopy
Part of Digestive system clinical trials.
This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 65 and 80 years old.
- Your body mass index (BMI) must be between 18 and 30.
- You must not be frail according to a simple frailty score (Fried score less than 3).
- Your mental state must be good (score of 27 or higher on a memory and thinking test).
- You cannot have taken any sedatives or pain medicines in the 24 hours before the procedure.
- You must not have serious liver or kidney problems, or allergies to the study drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a sedative called remimazolam and how it makes people feel during routine upper and lower GI scope procedures. It may help doctors understand which patients are more likely to feel a sense of euphoria (a feeling of intense happiness) from the medicine.
This trial tests a sedative called remimazolam besylate in patients who need a breathing tube and light sedation after non-cardiac surgery. The goal is to see if it works well and is safe.
This study tests a combination of two medicines to see how well it works for sedation during a painless endoscopy (a tube test of the stomach) in people with obesity. It aims to find the best dose for safer and more comfortable procedures.
This trial compares two ways to keep you comfortable during a scope procedure (like colonoscopy or endoscopy): one using opioid pain medications, and one without. Researchers want to see if avoiding opioids is safe and effective.
This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.
This trial tests a combination of two sedative medicines (Remimazolam and Esketamine) for elderly patients having a painless stomach and colon exam. The goal is to see if this combination is safe and effective for older adults.
Hear when a new Gastrointestinal Endoscopy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.